Cargando…
Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy
Independent of tumor type and non‐invasive or minimally‐invasive feature, current physical treatments including ultrasound therapy, microwave ablation (MWA), and radiofrequency ablation (RFA) are widely used as the local treatment methods in clinics for directly killing tumors and activating systema...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561875/ https://www.ncbi.nlm.nih.gov/pubmed/36002305 http://dx.doi.org/10.1002/advs.202203921 |
_version_ | 1784808043708416000 |
---|---|
author | Liu, Qiaoqiao Zhang, Wei Jiao, Rong Lv, Zheng Lin, Xia Xiao, Yunping Zhang, Kun |
author_facet | Liu, Qiaoqiao Zhang, Wei Jiao, Rong Lv, Zheng Lin, Xia Xiao, Yunping Zhang, Kun |
author_sort | Liu, Qiaoqiao |
collection | PubMed |
description | Independent of tumor type and non‐invasive or minimally‐invasive feature, current physical treatments including ultrasound therapy, microwave ablation (MWA), and radiofrequency ablation (RFA) are widely used as the local treatment methods in clinics for directly killing tumors and activating systematic immune responses. However, the activated immune responses are inadequate and incompetent for tumor recession, and the incomplete thermal ablation even aggravates the immunosuppressive tumor microenvironment (ITM), resulting in the intractable tumor recurrence and metastasis. Intriguingly, nanomedicine provides a powerful platform as they can elevate energy utilization efficiency and augment oncolytic effects for mitigating ITM and potentiating the systematic immune responses. Especially after combining with clinical immunotherapy, the anti‐tumor killing effect by activating or enhancing the human anti‐tumor immune system is reached, enabling the effective prevention against tumor recurrence and metastasis. This review systematically introduces the cutting‐edge progress and direction of nanobiotechnologies and their corresponding nanomaterials. Moreover, the enhanced physical treatment efficiency against tumor progression, relapse, and metastasis via activating or potentiating the autologous immunity or combining with exogenous immunotherapeutic agents is exemplified, and their rationales are analyzed. This review offers general guidance or directions to enhance clinical physical treatment from the perspectives of immunity activation or magnification. |
format | Online Article Text |
id | pubmed-9561875 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95618752022-10-16 Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy Liu, Qiaoqiao Zhang, Wei Jiao, Rong Lv, Zheng Lin, Xia Xiao, Yunping Zhang, Kun Adv Sci (Weinh) Reviews Independent of tumor type and non‐invasive or minimally‐invasive feature, current physical treatments including ultrasound therapy, microwave ablation (MWA), and radiofrequency ablation (RFA) are widely used as the local treatment methods in clinics for directly killing tumors and activating systematic immune responses. However, the activated immune responses are inadequate and incompetent for tumor recession, and the incomplete thermal ablation even aggravates the immunosuppressive tumor microenvironment (ITM), resulting in the intractable tumor recurrence and metastasis. Intriguingly, nanomedicine provides a powerful platform as they can elevate energy utilization efficiency and augment oncolytic effects for mitigating ITM and potentiating the systematic immune responses. Especially after combining with clinical immunotherapy, the anti‐tumor killing effect by activating or enhancing the human anti‐tumor immune system is reached, enabling the effective prevention against tumor recurrence and metastasis. This review systematically introduces the cutting‐edge progress and direction of nanobiotechnologies and their corresponding nanomaterials. Moreover, the enhanced physical treatment efficiency against tumor progression, relapse, and metastasis via activating or potentiating the autologous immunity or combining with exogenous immunotherapeutic agents is exemplified, and their rationales are analyzed. This review offers general guidance or directions to enhance clinical physical treatment from the perspectives of immunity activation or magnification. John Wiley and Sons Inc. 2022-08-24 /pmc/articles/PMC9561875/ /pubmed/36002305 http://dx.doi.org/10.1002/advs.202203921 Text en © 2022 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Liu, Qiaoqiao Zhang, Wei Jiao, Rong Lv, Zheng Lin, Xia Xiao, Yunping Zhang, Kun Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy |
title | Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy |
title_full | Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy |
title_fullStr | Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy |
title_full_unstemmed | Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy |
title_short | Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy |
title_sort | rational nanomedicine design enhances clinically physical treatment‐inspired or combined immunotherapy |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561875/ https://www.ncbi.nlm.nih.gov/pubmed/36002305 http://dx.doi.org/10.1002/advs.202203921 |
work_keys_str_mv | AT liuqiaoqiao rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy AT zhangwei rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy AT jiaorong rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy AT lvzheng rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy AT linxia rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy AT xiaoyunping rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy AT zhangkun rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy |